✦ LIBER ✦

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu

✍ Scribed by Alessandro D. Santin; Stefania Bellone; Juan J. Roman; Jesse K. McKenney; Sergio Pecorelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab (T) plus oral vinorelbine (O

✍ C. Catania; Adamoli; L. Franceschelli; C. Marenghi; G. Ascione; G. Sanna; E. Ver 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Overexpression of HER-2/neu in endometri

✍ A. Berchuck; G. Rodriguez; R.B. Kinney; J.T. Soper; D.L. Clarke-Pearson; R.C. Ba 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase II trial of trastuzumab in women w

✍ Gini F. Fleming; Michael W. Sill; Kathleen M. Darcy; D. Scott McMeekin; J. Tate 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 477 KB

Trastuzumab (Herceptin®) in patients wit

✍ Marc Salzberg; Markus Borner; Jean-Alexandre Bauer; Rudolf Morant; Daniel Rauch; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Overexpression of HER-2/neu in endometri

✍ A Berchuck; G Rodriguez; R.B Kinney; JT Soper; RK Dodge; DL Clarke-Pearson; RC B 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Treatment of Advanced or Recurrent Endom

✍ Thomas W. Burke; Adnan Munkarah; John J. Kavanagh; Mitchell Morris; Charles Leve 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 235 KB